Objective: To identify characteristics that distinguish cardiac from vasovagal syncope.

Study Design: We compared characteristics of patients ≤18 years of age with vasovagal and cardiac syncope. Vasovagal syncope subjects represented all patients presenting to outpatient cardiology during a 1-year period for initial evaluation of syncope diagnosed with vasovagal syncope. Cardiac patients were all patients identified by review of diagnoses known to include syncope as a symptom who presented with syncope to the emergency department or inpatient or outpatient cardiology during a 10-year period identified with cardiac etiology.

Results: There were 89 patients 4-18 years of age with vasovagal syncope and 17 patients 4 months to 17 years of age with cardiac syncope. When we compared patients with cardiac syncope to those with vasovagal syncope, we found that syncope surrounding activity was present in 65% vs 18% (P < .001), family history of cardiac disease or sudden cardiac death was identified in 41% vs 25% (P = .2), abnormal findings on the physical examination supporting cardiac diagnosis were present in 29% vs 0% (P < .001), and abnormal findings on electrocardiograms were found in 76% vs 0%, respectively (P < .001). Screening for cardiac disease using any 1 of these 4 characteristics had a sensitivity of 100% and specificity of 60%. Using this screening rule, we found that 60% of patients with vasovagal syncope would not have been referred to cardiology.

Conclusions: Cardiac and vasovagal syncope have dramatic differences in presentation. A screening rule that uses historic features, physical examination findings, and electrocardiogram will accurately separate patients requiring further evaluation for cardiac etiology from those with vasovagal syncope in whom cardiology referral is unnecessary.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jpeds.2013.07.023DOI Listing

Publication Analysis

Top Keywords

vasovagal syncope
32
syncope
16
cardiac syncope
16
syncope vasovagal
12
cardiac
12
years age
12
vasovagal
10
patients
9
cardiac vasovagal
8
age vasovagal
8

Similar Publications

Syncope: Advances in Diagnosis and Treatment 2024.

J Cardiovasc Electrophysiol

December 2024

Arrhythmia Center Mail Code 508, University of Minnesota, Minneapolis, Minnesota, USA.

Aim: In light of many recent advances in the field of vasovagal syncope, a selective review has been undertaken of these developments.

Methods: Recent publications on the following topics were reviewed; understanding of vasovagal syncope pathophysiology, tilt-testing methodology and interpretation, drug, ablation and pacemaker therapy.

Results And Conclusions: The vasovagal syncope field is very active in researching its pathophysiology, using it to gain better understanding of the process and applying this knowledge to therapy.

View Article and Find Full Text PDF

Vasovagal Syncope: A Review of Current and Emerging Therapies for a Common Cardiology Condition.

J Tehran Heart Cent

January 2024

Department of Cardiac Sciences, Libin Cardiovascular Institute, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.

Vasovagal syncope (VVS), characterized by transient loss of consciousness, is among the most prevalent reasons for emergency visits worldwide. Although benign in nature, VVS can be accompanied by traumatic injury, leading to morbidity and decreased quality of life, especially in those with VVS recurrence. The management includes non-pharmacologic and pharmacologic therapies (if resistant), patient education and reassurance, salt and fluid intake increase, and physical counter-pressure maneuvers.

View Article and Find Full Text PDF

Background: Syncope is a common medical condition. The reflex or neurally mediated syncope (NMS) is the most frequent type. The tilt table test (TTT) helps distinguish syncope from other common causes of complete loss of consciousness, such as epilepsy, define syncope subtypes and guide management.

View Article and Find Full Text PDF

Malignant vasovagal syncope in children.

World J Pediatr

December 2024

Department of Pediatrics, Children's Medical Center, Peking University First Hospital, No. 8, Xishiku Street, West District, Beijing, 100034, China.

Background: Malignant vasovagal syncope (VVS) is a unique form of cardioinhibitory VVS, characterized by prolonged asystole. To deepen the understanding of this distinct type of VVS in children, this article reviews advancements in the potential pathogenesis, diagnostic approaches, clinical significance, and treatment controversies of malignant VVS in pediatric patients.

Data Sources: This article was developed by reviewing the literature and studies in databases including PubMed and Chinese Journal Full-text Database up to September 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!